GlassScriptPhysician profile
Mark Adam Krel
NPI 1326450685
$12,923.13
in general payments reported to CMS, 2019-2025
30 companies · $3,677 in 2025
The $3,677 reported for 2025 was more than what 77% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $348 · 2022: $2,094 · 2023: $3,245 · 2024: $3,559 · 2025: $3,677.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,320 · Travel and Lodging: $1,161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,319.91 |
| Travel and Lodging | $1,160.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,133.96 | 2021-2025 | General - Dbs, Linear, Spectra Wavewriter |
| Medtronic, INC. | $3,119.79 | 2022-2025 | Intellis Adaptivestim, Synchromedii, Percept PC Brainsense |
| Abbott Laboratories | $992.96 | 2022-2025 | Eterna, Proclaim, Infinity |
| Nevro Corp. | $857.12 | 2022-2024 | Senza |
| Biotronik Nro, INC. | $679.90 | 2024-2025 | Prospera |
| Neuropace, INC. | $586.17 | 2023-2025 | |
| Stryker Corporation | $358.71 | 2022-2024 | Everest Spinal System, Na, Adherus Autospray Dural Sealant |
| Saluda Medical Americas, INC. | $345.27 | 2024-2025 | Evoke |
| Monteris Medical Corporation | $295.92 | 2022-2025 | Neuroblate |
| Neurocrine Biosciences, INC. | $212.09 | 2023-2024 | Ingrezza, Ongentys |
| Globus Medical, INC. | $186.16 | 2025 | Senza, X-Core, Fortify |
| Ucb, INC. | $160.30 | 2023-2025 | Rystiggo, Briviact, Fintepla |
| Neurelis, INC. | $146.44 | 2024-2025 | Valtoco |
| Sk Life Science, INC. | $101.60 | 2024-2025 | |
| Ceribell, INC. | $99.68 | 2023 | Ceribell Rapid Response Eeg |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $95.43 | 2024-2025 | |
| Livanova USA, INC. | $89.94 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Depuy Synthes Sales INC. | $80.11 | 2023-2025 | Trumatch, Na, Matrixneuro |
| Zimmer Biomet Holdings, INC. | $74.13 | 2023 | Rosa |
| Idorsia Pharmaceuticals US INC | $62.72 | 2023 | Quviviq |
| Ecential Robotics | $46.58 | 2025 | |
| Integra Lifesciences Corporation | $35.90 | 2022-2024 | Duraseal Exact Spinal Sealant System, Codman Hakim, Codman Certas |
| Biogen, INC. | $28.25 | 2024 | Skyclarys |
| Piramal Critical Care | $23.82 | 2024 | |
| Mimedx Group, INC. | $23.27 | 2024 | |
| Lilly USA, LLC | $21.73 | 2024 | Emgality |
| Emd Serono, INC. | $18.91 | 2022 | |
| Nalu Medical, INC. | $16.62 | 2024 | Nalu Neurostimulation System |
| Acorda Therapeutics, INC | $15.89 | 2023 | Inbrija |
| Otsuka America Pharmaceutical, INC. | $13.76 | 2024 | Nuedexta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Krel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.